These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15321023)

  • 21. The Relationship of Brimonidine Concentration in Vitreous Body to the Free Concentration in Retina/Choroid Following Topical Administration in Pigmented Rabbits.
    Shinno K; Kurokawa K; Kozai S; Kawamura A; Inada K; Tokushige H
    Curr Eye Res; 2017 May; 42(5):748-753. PubMed ID: 27854122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aqueous humor flow in normal human eyes treated with brimonidine and dorzolamide, alone and in combination.
    Tsukamoto H; Larsson LI
    Arch Ophthalmol; 2004 Feb; 122(2):190-3. PubMed ID: 14769595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine.
    Kim SN; Ko SA; Park CG; Lee SH; Huh BK; Park YH; Kim YK; Ha A; Park KH; Choy YB
    Mol Pharm; 2018 Aug; 15(8):3143-3152. PubMed ID: 30020792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular Pharmacokinetics of Brimonidine Drug Delivery System in Monkeys and Translational Modeling for Selection of Dose and Frequency in Clinical Trials.
    Tamhane M; Luu KT; Attar M
    J Pharmacol Exp Ther; 2021 Sep; 378(3):207-214. PubMed ID: 34210753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes.
    Acheampong AA; Shackleton M; John B; Burke J; Wheeler L; Tang-Liu D
    Drug Metab Dispos; 2002 Apr; 30(4):421-9. PubMed ID: 11901096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
    Kahook MY; Noecker RJ
    Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations.
    Alonso RS; Solari HP; de França Damasceno E; Burnier MNN; Ventura MP
    BMC Pharmacol Toxicol; 2020 Mar; 21(1):24. PubMed ID: 32293549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzalkonium chloride induces anterior chamber inflammation in previously untreated patients with ocular hypertension as measured by flare meter: a randomized clinical trial.
    Stevens AM; Kestelyn PA; De Bacquer D; Kestelyn PG
    Acta Ophthalmol; 2012 May; 90(3):e221-4. PubMed ID: 22489894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained ocular delivery of brimonidine tartrate using ion activated in situ gelling system.
    Geethalakshmi A; Karki R; Jha SK; Venkatesh DP; Nikunj B
    Curr Drug Deliv; 2012 Mar; 9(2):197-204. PubMed ID: 22283647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions.
    Liang H; Brignole-Baudouin F; Riancho L; Baudouin C
    Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular pharmacokinetics profile of different indomethacin topical formulations.
    Bucolo C; Melilli B; Piazza C; Zurria M; Drago F
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of benzalkonium chloride on the blood-aqueous and blood-retinal barriers of pseudophakic eyes.
    Abe RY; Zacchia RS; Santana PR; Costa VP
    J Ocul Pharmacol Ther; 2014 Jun; 30(5):413-8. PubMed ID: 24660827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Solution pH on Distribution of Ophthalmically Administered Brimonidine in Posterior Ocular Tissues in Pigmented Rabbits.
    Shinno K; Kurokawa K; Kozai S; Kawamura A; Inada K; Tokushige H
    Ophthalmol Ther; 2019 Jun; 8(2):271-277. PubMed ID: 30891685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells.
    Brignole-Baudouin F; Riancho L; Liang H; Baudouin C
    Curr Eye Res; 2011 Nov; 36(11):979-88. PubMed ID: 21999224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rapid and sensitive LC/MS/MS assay for the quantitation of brimonidine in ocular fluids and tissues.
    Jiang S; Chappa AK; Proksch JW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):107-14. PubMed ID: 19109079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects.
    Konstas AG; Karabatsas CH; Lallos N; Georgiadis N; Kotsimpou A; Stewart JA; Stewart WC
    Ophthalmology; 2005 Apr; 112(4):603-8. PubMed ID: 15808251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
    Ammar DA; Noecker RJ; Kahook MY
    Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study.
    Orii Y; Kunikane E; Yamada Y; Morioka M; Iwasaki K; Arimura S; Mizuno A; Inatani M
    J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capillary electrophoretic analysis of brimonidine in aqueous humor of the eye and blood sera and relation of its levels with intraocular pressure.
    Tzovolou DN; Lamari F; Mela EK; Gartaganis SP; Karamanos NK
    Biomed Chromatogr; 2000 Aug; 14(5):301-5. PubMed ID: 10960828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dilution of benzalkonium chloride (BAK) in the tear film.
    Friedlaender MH; Breshears D; Amoozgar B; Sheardown H; Senchyna M
    Adv Ther; 2006; 23(6):835-41. PubMed ID: 17276951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.